You are viewing the site in preview mode
Skip to main content
|
Antimicrobial group
|
DOT (days)
|
p value
|
DDD
|
p value
|
|---|
|
Microbiologically confirmed N = 649
|
Microbiologically unconfirmed N = 118
|
Microbiologically confirmed N = 649
|
Microbiologically unconfirmed N = 118
|
|---|
|
Median (IQR)
|
Median (IQR)
|
Median (IQR)
|
Median (IQR)
|
|---|
|
Aminoglycosides
|
7.0 (5.0; 9.3)
|
7.0 (6.0;7.0)
|
0.5265
|
0.101 (0.050; 0.171)
|
0.095 (0.045; 0.179)
|
<0.0001
|
|
Antimycotic
|
12.5 (9.0;16.0)
|
10.0 (7.8;14.3)
|
0.210 (0.132; 0.040)
|
0.198 (0.073; 0.463)
|
|
Beta-lactams
|
8.0 (5.0;11.0)
|
7.0 (6.8;8.8)
|
0.254 (0.136; 0.438)
|
0.300 (0.210; 0.420)
|
|
Glycopeptides
|
10.0 (8.0;11.0)
|
9.0 (7.0;11.0)
|
0.120 (0.080; 0.168)
|
0.120 (0.083; 0.146)
|
|
Other
|
9.0 (6.0;14.8)
|
8.0 (5.0;15.5)
|
0.210 (0.105; 0.530)
|
0.098 (0.060; 0.410)
|
|
Total
|
8.0 (5.0; 16.0)
|
7.0 (5.0; 15.5)
|
0.120 (0.050; 0.530)
|
0.143 (0.045; 0.463)
|
-
DOT days of therapy (per one infection case), DDD defined daily dose (per one infection case), IQR interquartile range, N number of BSI cases
